Molecule Details
| InChIKey | NGOGFTYYXHNFQH-UHFFFAOYSA-N |
|---|---|
| Compound Name | Fasudil |
| Canonical SMILES | O=S(=O)(c1cccc2cnccc12)N1CCCNCC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 15 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.43 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB08162 |
|---|---|
| Drug Name | Fasudil |
| CAS Number | 103745-39-7 |
| Groups | investigational |
| ATC Codes | C04AX32 |
| Description | Fasudil has been investigated in Carotid Stenosis. |
Categories: Antiarrhythmic agents Calcium Channel Blockers Calcium-Regulating Hormones and Agents Cardiovascular Agents Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Isoquinolines Membrane Transport Modulators Peripheral Vasodilators Piperazines Protein Kinase Inhibitors Sulfonamides Sulfones Sulfur Compounds Vasodilating Agents
Cross-references: BindingDB: 14027 CHEMBL38380 ChemSpider: 3426 PDB: M77 PubChem:3547 PubChem:99444633 Wikipedia: Fasudil ZINC: ZINC000000006486
Target Activities (15)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P51817 | PRKX | Homo sapiens | Human | PF00069 | 7.3 | Ki | ChEMBL |
| Q6P5Z2 | PKN3 | Homo sapiens | Human | PF02185 PF00069 PF00433 | 7.0 | Kd | ChEMBL |
| P49759 | CLK1 | Homo sapiens | Human | PF00069 | 6.8 | Kd | ChEMBL |
| P17612 | PRKACA | Homo sapiens | Human | PF00069 | 6.7 | Ki | ChEMBL;BindingDB |
| O75116 | ROCK2 | Homo sapiens | Human | PF25346 PF00069 PF08912 | 6.6 | IC50 | ChEMBL;BindingDB |
| Q13464 | ROCK1 | Homo sapiens | Human | PF25346 PF00069 PF08912 | 6.5 | IC50 | ChEMBL;BindingDB |
| Q9HAZ1 | CLK4 | Homo sapiens | Human | PF00069 | 6.5 | Ki | ChEMBL |
| P22612 | PRKACG | Homo sapiens | Human | PF00069 | 6.3 | Ki | ChEMBL |
| P22694 | PRKACB | Homo sapiens | Human | PF00069 | 6.3 | Ki | ChEMBL |
| Q04759 | PRKCQ | Homo sapiens | Human | PF00130 PF21494 PF00069 PF00433 | 6.2 | Ki | ChEMBL |
| Q16513 | PKN2 | Homo sapiens | Human | PF02185 PF00069 PF00433 | 6.1 | IC50 | ChEMBL;BindingDB |
| Q16512 | PKN1 | Homo sapiens | Human | PF02185 PF00069 PF00433 | 6.1 | Kd | ChEMBL |
| O94806 | PRKD3 | Homo sapiens | Human | PF00130 PF00169 PF00069 PF25525 | 6.0 | Ki | ChEMBL |
| P23443 | RPS6KB1 | Homo sapiens | Human | PF00069 PF00433 | 6.0 | Ki | ChEMBL |
| P51812 | RPS6KA3 | Homo sapiens | Human | PF00069 PF00433 | 6.0 | Ki | ChEMBL |
DrugBank Target Actions (4)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| O75116 | ROCK2 | Rho-associated protein kinase 2 | binder | targets |
| P17612 | PRKACA | cAMP-dependent protein kinase catalytic subunit alpha | binder | targets |
| P61925 | P61925 | cAMP-dependent protein kinase inhibitor alpha | binder | targets |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | inhibitor | targets |